EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

T cell immunity and the etiology and pathogenesis of preeclampsia

Shigeru Saito, Sayaka Tsuda, Akitoshi Nakashima

Journal of Reproductive Immunology · 2023-09 · 159 · 104125

DOI: 10.1016/j.jri.2023.104125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Reproductive Immunology, 2023-09. Verfasst von Shigeru Saito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, Japan. Electronic address: s30saito@med.u-toyama.ac…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Abortion, Habitual. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia is more common in nulliparous women, their first pregnancies with a new partner in multiparous women, pregnant women with short duration of cohabitation, and in pregnancies with donor eggs, where the fetus is completely foreign to the mother. The epidemiological study findings strongly suggest that inadequate induction of tolerance to paternal/fetal antigens is involved in the pathogenesis of preeclampsia. This review proposes that preeclampsia may be caused by a reduction in paternal/fetal antigen-specific regulatory T (Treg) cells and decreased PD-1 expression on clonally expanded CD8+ effector memory T (TEM) cells, resulting in a breakdown of mother-to-fetus tolerance. The immune environment of preeclampsia is clearly different from that of recurrent pregnancy loss (RPL). In preeclampsia, cloned Treg cells decreases, and PD-1 expression on cloned CD8+TEM decreased. In RPL, the total number of Treg cells decreased, and the total number of clonally expanded CD8+TEM cells increases. In addition to these changes, increased differentiation of Th17 cells has also been observed in preeclampsia. This change is caused by soluble endoglin, that is increased in preeclampsia, neutralizing TGFβ. These immunological changes make the fetus more susceptible to attacks from maternal T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaAbortion, HabitualFemaleHumansPregnancyProgrammed Cell Death 1 ReceptorT-Lymphocytes, RegulatoryAntigensImmune Tolerance

Stichwörter der Autor:innen

CD8(+)T cellsPaternal antigensPreeclampsiaRecurrent pregnancy lossRegulatory T cells

Substanzen

Programmed Cell Death 1 ReceptorAntigens

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, Japan. Electronic address: s30saito@med.u-toyama.ac.jp.
  • Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, Japan.

Zitieren

APA

Saito, S., Tsuda, S., & Nakashima, A. (2023). T cell immunity and the etiology and pathogenesis of preeclampsia. Journal of Reproductive Immunology, 159, 104125. https://doi.org/10.1016/j.jri.2023.104125

Vancouver

Saito S, Tsuda S, Nakashima A. T cell immunity and the etiology and pathogenesis of preeclampsia. Journal of Reproductive Immunology. 2023;159:104125. doi:10.1016/j.jri.2023.104125

BibTeX
@article{Saito2023,
  author = {Saito, Shigeru and Tsuda, Sayaka and Nakashima, Akitoshi},
  title = {T cell immunity and the etiology and pathogenesis of preeclampsia},
  journal = {Journal of Reproductive Immunology},
  year = {2023},
  volume = {159},
  pages = {104125},
  doi = {10.1016/j.jri.2023.104125}
}
Kostenlos starten →